92 related articles for article (PubMed ID: 16563503)
1. Mantle cell lymphoma-derived cell lines: unique research tools.
Drexler HG; MacLeod RA
Leuk Res; 2006 Aug; 30(8):911-3. PubMed ID: 16563503
[No Abstract] [Full Text] [Related]
2. Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines.
Camps J; Salaverria I; Garcia MJ; Prat E; Beà S; Pole JC; Hernández L; Del Rey J; Cigudosa JC; Bernués M; Caldas C; Colomer D; Miró R; Campo E
Leuk Res; 2006 Aug; 30(8):923-34. PubMed ID: 16448697
[TBL] [Abstract][Full Text] [Related]
3. Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519.
Rudolph C; Steinemann D; Von Neuhoff N; Gadzicki D; Ripperger T; Drexler HG; Mrasek K; Liehr T; Claussen U; Emura M; Schrock E; Schlegelberger B
Cancer Genet Cytogenet; 2004 Sep; 153(2):144-50. PubMed ID: 15350304
[TBL] [Abstract][Full Text] [Related]
4. Mantle cell lymphoma with triple-fusion signals of immunoglobulin heavy chain locus/cyclin D1 gene by fluorescence in situ hybridization.
Kuroda N; Taniguchi Y; Miyazaki E; Inagaki K
Pathol Int; 2006 Aug; 56(8):478-9. PubMed ID: 16872445
[No Abstract] [Full Text] [Related]
5. Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations.
Sander S; Bullinger L; Leupolt E; Benner A; Kienle D; Katzenberger T; Kalla J; Ott G; Müller-Hermelink HK; Barth TF; Möller P; Lichter P; Döhner H; Stilgenbauer S
Haematologica; 2008 May; 93(5):680-7. PubMed ID: 18367489
[TBL] [Abstract][Full Text] [Related]
6. The use of microarray technologies in mantle cell lymphoma.
Ratsch BA; Grau M; Dörken B; Lenz P; Lenz G
Semin Hematol; 2011 Jul; 48(3):166-71. PubMed ID: 21782058
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous blastoid mantle cell lymphoma-case report.
Estrozi B; Sanches JA; Varela PC; Bacchi CE
Am J Dermatopathol; 2009 Jun; 31(4):398-400. PubMed ID: 19461249
[TBL] [Abstract][Full Text] [Related]
8. Rapid diagnosis of orbital mantle cell lymphoma utilizing fluorescent in situ hybridization technology.
Coffee R; Lazarchick J; Chévez-Barrios P; Howard G
Am J Ophthalmol; 2005 Sep; 140(3):554-6. PubMed ID: 16139018
[TBL] [Abstract][Full Text] [Related]
9. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques.
Salaverria I; Espinet B; Carrió A; Costa D; Astier L; Slotta-Huspenina J; Quintanilla-Martinez L; Fend F; Solé F; Colomer D; Serrano S; Miró R; Beà S; Campo E
Genes Chromosomes Cancer; 2008 Dec; 47(12):1086-97. PubMed ID: 18709664
[TBL] [Abstract][Full Text] [Related]
10. Composite mantle-cell lymphoma and classical Hodgkin lymphoma.
Hayes SJ; Banerjee SS; Cook Y; Houghton JB; Menasce LP
Histopathology; 2006 Apr; 48(5):621-3. PubMed ID: 16623796
[No Abstract] [Full Text] [Related]
11. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
Yoo SB; Kim YA; Jeon YK; Kim CW
Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
[TBL] [Abstract][Full Text] [Related]
12. A novel sporadic Burkitt lymphoma cell line (BLUE-1) with a unique t(6;20)(q15;q11.2) rearrangement.
Burmeister T; Macleod RA; Reinhardt R; Mansmann V; Loddenkemper C; Marinets O; Drexler HG; Thiel E; Blau IW
Leuk Res; 2006 Nov; 30(11):1417-23. PubMed ID: 16697040
[TBL] [Abstract][Full Text] [Related]
13. Mantle cell lymphoma arising within primary nodal marginal zone lymphoma: a unique presentation of two uncommon B-cell lymphoproliferative disorders.
Rodig SJ; Healey BM; Pinkus GS; Kuo FC; Dal Cin P; Kutok JL
Cancer Genet Cytogenet; 2006 Nov; 171(1):44-51. PubMed ID: 17074590
[TBL] [Abstract][Full Text] [Related]
14. Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes.
Schraders M; Jares P; Bea S; Schoenmakers EF; van Krieken JH; Campo E; Groenen PJ
Br J Haematol; 2008 Oct; 143(2):210-21. PubMed ID: 18699851
[TBL] [Abstract][Full Text] [Related]
15. Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma.
Flordal Thelander E; Ichimura K; Collins VP; Walsh SH; Barbany G; Hagberg A; Laurell A; Rosenquist R; Larsson C; Lagercrantz S
Leuk Res; 2007 Sep; 31(9):1219-30. PubMed ID: 17161458
[TBL] [Abstract][Full Text] [Related]
16. Sample pooling in 2-D gel electrophoresis: a new approach to reduce nonspecific expression background.
Weinkauf M; Hiddemann W; Dreyling M
Electrophoresis; 2006 Nov; 27(22):4555-8. PubMed ID: 17066383
[TBL] [Abstract][Full Text] [Related]
17. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma.
Chim CS; Wong KY; Loong F; Lam WW; Srivastava G
Hum Pathol; 2007 Dec; 38(12):1849-57. PubMed ID: 17900658
[TBL] [Abstract][Full Text] [Related]
18. PRAME is a membrane and cytoplasmic protein aberrantly expressed in chronic lymphocytic leukemia and mantle cell lymphoma.
Proto-Siqueira R; Figueiredo-Pontes LL; Panepucci RA; Garcia AB; Rizzatti EG; Nascimento FM; Ishikawa HC; Larson RE; Falcão RP; Simpson AJ; Gout I; Filonenko V; Rego EM; Zago MA
Leuk Res; 2006 Nov; 30(11):1333-9. PubMed ID: 16620968
[TBL] [Abstract][Full Text] [Related]
19. Extranodal plasmablastic lymphoma arising in mantle cell lymphoma.
Cooper CL; Joshua DE; Lee CS; Eyers AA; Cooper WA
Histopathology; 2007 Dec; 51(6):856-9. PubMed ID: 17903200
[No Abstract] [Full Text] [Related]
20. Cryptic and complex chromosomal rearrangements and the deletion of TP53 gene in a patient with leukemic mantle cell lymphoma.
Zhang L; Kern WF; Yu Z; Mulvihill JJ; Li S
Cancer Genet Cytogenet; 2006 Sep; 169(2):169-73. PubMed ID: 16938577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
